Lipid Management Beyond Statins: Biologic Basis, New Clinical Evidence and Strategies- Enduring Activity

Peter Libby, MD, is a cardiovascular specialist at Brigham and Women's Hospital in Boston, Massachusetts, and holds the Mallinckrodt Professorship of Medicine at Harvard Medical School. He served as Chief of Cardiovascular Medicine at BWH from 1998 - 2014. His areas of clinical expertise include general and preventive cardiology. His current major research focus is the role of inflammation in vascular diseases such as atherosclerosis. Dr. Libby has received numerous awards and recognitions for his research accomplishments, including the Gold Medal of the European Society of Cardiology (2011), the Basic Research Prize of the American Heart Association (2011), the Anitschkow Prize in Atherosclerosis Research of the European Atherosclerosis Society (2013), and the Distinguished Achievement Award of the Heart Failure Association of the European Society of Cardiology (2014).
Dr. Libby's professional memberships include the Association of American Physicians, the American Society for Clinical Investigation, and elected honorary memberships in the British Atherosclerosis Society, the Japan Circulation Society, and the Japanese College of Cardiology. He has served as the President of the Association of University Cardiologists. He also has served in many roles as a volunteer for the American Heart Association, including chairman of several research committees and member of the executive committees of the Councils on Arteriosclerosis, Circulation, and Basic Science. He presided the American College of Cardiology's Research Allocations Peer Review Committee for two terms. He has frequently consulted for the National Heart, Lung, and Blood Institute, including a 5-year term on the Board of Scientific Councilors. He directed the DW Reynolds Cardiovascular Clinical Research Center and two cycles of Leducq Foundation Awards, and has received continuous funding from the NHLBI for several decades.
An author and lecturer on cardiovascular medicine and atherosclerosis, Dr. Libby has published extensively in medical journals including Circulation, Journal of Clinical Investigation, Proceedings of the National Academy of Sciences, New England Journal of Medicine, and Nature. He is an Editor of Braunwald's Heart Disease. Dr. Libby also contributed chapters on the pathogenesis, treatment, and prevention of atherosclerosis to many editions of Harrison's Principles of Internal Medicine. He has held numerous visiting professorships and delivered more than 80 major named or keynote lectures throughout the world.
Dr. Libby earned his medical degree at the University of California, San Diego, and completed his training in internal medicine and cardiology at the Peter Bent Brigham Hospital (now Brigham and Women's Hospital). He also holds an honorary MA degree from Harvard University, and an honorary doctorate from the University of Lille, France
 

Dr. Harold Bays is Board Certified in Endocrinology and Internal Medicine, and has participated as an Investigator for over 400 Phase I - IV clinical trials regarding treatments for dyslipidemias, obesity, diabetes mellitus, hypertension, and other metabolic and hormonal disorders. As Medical Director and President of Louisville Metabolic and Atherosclerosis Research Center, Dr. Bays has written, or served as a contributing author to ~ 200 published scientific manuscripts and book chapters, as well as over 100 scientific abstracts presented at major scientific meetings. He is a Fellow of the National Lipid Association (FNLA), Fellow of The Obesity Society (FTOS), and Fellow of the American Association of Clinical Endocrinologists (FACE). He has served as an advisor/consultant to numerous pharmaceutical companies with regard to drug development, protocol writing, statistical analyses, regulatory application, FDA Advisory panel presentations, and patent assistance. Dr. Bays originated the term "adiposopathy" ("sick fat"), which defines how and when the pathologic consequences of adipose tissue accumulation promotes metabolic disease, including dyslipidemia, diabetes mellitus, and hypertension.  Dr. Bays is a co-author of the American Society of Bariatric Physician Obesity Algorithm, and was Chairman of the National Lipid Association 2012 Adiposity and Dyslipidemia Consensus Conference and Chairman of the 2010 American Association of Clinical Endocrinologist Adipose Tissue Pathophysiology State of the Science Conference.
 

Dr. Miller is Professor of Medicine, Epidemiology and Public Health at the University of Maryland School of Medicine with ABIM certification in internal medicine and recertification in cardiovascular disease. He is also also a Diplomate of Clinical Lipidology. Dr. Miller has authored more than 250 original articles, book chapters and other publications that have appeared in BMJ, Circulation, JACC, JAMA, NEJM, PNAS and Science.  He is the co-author of "The Practice of Coronary Disease Prevention" (Lippincott, Williams & Wilkins, 1996), "The AMA Guide to Preventing and Treating Heart Disease" (Wiley, 2008) and "Heal Your Heart, The Positive Emotions Prescription to Prevent and Reverse Heart Disease" (Rodale, 2014).   Dr. Miller has contributed to the American College of Cardiology Self-Assessment Program (ACCSAP) for board certification and chaired the AHA Scientific Statement: Triglycerides and Cardiovascular Disease.   Currently, he is a Member of the AHA Nutrition Committee of the Lifestyle and Cardiometabolic Health Council and serves on Governor Martin O'Malley's Advisory Council on Heart Disease and Stroke Prevention.